Increased circulating levels of matrix metalloproteinase (MMP)-8, MMP-9, and pro-inflammatory markers in patients with metabolic syndrome
- 28 February 2009
- journal article
- research article
- Published by Elsevier in Clinica Chimica Acta; International Journal of Clinical Chemistry
- Vol. 403 (1-2), 173-177
- https://doi.org/10.1016/j.cca.2009.02.013
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Enhanced concentrations of relevant markers of nitric oxide formation after exercise training in patients with metabolic syndromeNitric Oxide, 2008
- Inflammatory markers in relation to insulin resistance and the metabolic syndromeEuropean Journal of Clinical Investigation, 2008
- Inflammation, the metabolic syndrome, and risk of coronary heart disease in women and menAtherosclerosis, 2008
- Matrix metalloproteinases and their inhibitors in vascular remodeling and vascular diseaseBiochemical Pharmacology, 2007
- Inflammatory Markers and the Metabolic SyndromeJournal of the American College of Cardiology, 2005
- Diagnosis and Management of the Metabolic SyndromeCirculation, 2005
- Plasma Matrix Metalloproteinase-9, Tissue Inhibitor of Metalloproteinase-2, and CD40 Ligand Levels in Patients With Stable Coronary Artery DiseaseThe American Journal of Cardiology, 2005
- Dual Role of Matrix Metalloproteinases (Matrixins) in Intimal Thickening and Atherosclerotic Plaque RupturePhysiological Reviews, 2005
- Inflammation in atherosclerosisNature, 2002
- Immune Mechanisms in AtherosclerosisArteriosclerosis, Thrombosis, and Vascular Biology, 2001